LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 1, 2001, Pages 108-114

  Zhou, Xinghua ^a   Caligiuri, Giuseppina ^a   Hamsten, Anders ^a   Lefvert, Ann Kari ^a   Hansson, Göran K ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibodies; Atherosclerosis; Immunization; Low density lipoproteins; T cells

Indexed keywords

APOLIPOPROTEIN E; CARDIOLIPIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; ATHEROSCLEROSIS; CELL PROTECTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LIPID OXIDATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0035170994     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.1.108     Document Type: Article

References (52)

1. Atherosclerosis: An inflammatory disease
2. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
3. Are immunological mechanisms relevant for the development of atherosclerosis?
4. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
5. Immune and inflammatory mechanisms in the pathogenesis of atherosclerosis
6. Cell-mediated immunity in atherosclerosis
7. Atherosclerosis: Cell biology and lipoproteins
8. T lymphocytes in aortic and coronary intimas: Their potential role in atherogenesis
9. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
10. Detection of activated T lymphocytes in the human atherosclerotic plaque
11. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein
12. Evidence for a local immune response in atherosclerosis: CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice
13. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice
14. Atherosclerotic lesions in humans: In situ immunophenotypic analysis suggesting an immune mediated response
15. Expression of class II transplantation antigen on vascular smooth muscle Cells in human atherosclerosis
16. Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice
17. Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits
18. Immunoglobulins and complement components in human aortic atherosclerotic intima
19. Complement receptors and regulatory proteins in human atherosclerotic lesions
20. The oxidation hypothesis of atherosclerosis
21. Oxidized phosphatidylcholines that modify proteins: Analysis by monoclonal antibody against oxidized low density lipoprotein
22. Precision and reproducibility of ultrasonographic measurement of progression of common carotid artery atherosclerosis
23. Low density lipoprotein undergoes oxidative modification in vivo
24. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
25. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis
26. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
27. Cross-reaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
28. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein
29. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)
30. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis
31. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
32. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit
33. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a)
34. Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig
35. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis
36. Lysophosphatidylcholine. A chemotactic factor for human monocytes and its potential role in atherogenesis
37. Lysophosphatidylcholine. A component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
38. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
39. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients
40. Is atherosclerosis an immunologically mediated disease?
41. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
42. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits
43. Immunization of LDL receptor-deficient mice with homologous malondialdehydemodified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes
44. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis
45. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
46. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
47. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice
48. Quantitative assessment of atherosclerotic lesions in mice
49. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
50. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H)
51. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I
52. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree